Historical record - last NADAC effective date: 6/19/2024
Product Information
ALAHIST DM 10-12.5-5 MG/5 ML LQ is a generic product labeled by Poly Pharmaceuticals, Inc., priced at $0.0614 per ML under NDC 50991044416. Its NADAC has been published 52 times since Jun 19, 2024.
ALAHIST DM 10-12.5-5 MG/5 ML LQ
Dextromethorphan HBr, Pheniramine Maleate, Phenylephrine HClStrength
10; 12.5; 5 mg/5mL; mg/5mL; mg/5mL
Manufacturer
Poly Pharmaceuticals, Inc.NDC
50991044416
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
6/19/2024
Approval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
6/8/2023
Pharmacological Classes
Price Statistics
The NADAC for ALAHIST DM 10-12.5-5 MG/5 ML LQ has been published 52 times since Jun 19, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0614 per ML |
|---|---|
| All-time high | $0.0614 (Jun 11, 2025) |
| All-time low | $0.0614 (Jun 19, 2024) |
| Median price | $0.0614 |
| Average price | $0.0614 |
| Largest weekly change | 0.0% (Jun 26, 2024) |
| Weeks tracked | 52 |
| Tracking since | Jun 19, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Jun 11, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextromethorphan HBr, Pheniramine Maleate, Phenylephrine HCl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Poly Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextromethorphan HBr, Pheniramine Maleate, Phenylephrine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sigma-1 Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALAHIST DM 10-12.5-5 MG/5 ML LQ?
The current National Average Drug Acquisition Cost (NADAC) for ALAHIST DM 10-12.5-5 MG/5 ML LQ, manufactured by Poly Pharmaceuticals, Inc., is $0.0614 per ML (NDC 50991044416), effective Jun 11, 2025.
How has the price of ALAHIST DM 10-12.5-5 MG/5 ML LQ changed over time?
Over the history we have for it, the NADAC for ALAHIST DM 10-12.5-5 MG/5 ML LQ has held within roughly two percent of its current level. It has been tracked across 52 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for ALAHIST DM 10-12.5-5 MG/5 ML LQ?
Since Jun 19, 2024, the NADAC for ALAHIST DM 10-12.5-5 MG/5 ML LQ has ranged from a low of $0.0614 (Jun 19, 2024) to a high of $0.0614 (Jun 11, 2025), with a median of $0.0614 per ML.
Are there cheaper alternatives to ALAHIST DM 10-12.5-5 MG/5 ML LQ?
No other NADAC-published product currently shares the active ingredient and strength of ALAHIST DM 10-12.5-5 MG/5 ML LQ in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ALAHIST DM 10-12.5-5 MG/5 ML LQ?
ALAHIST DM 10-12.5-5 MG/5 ML LQ (NDC 50991044416) is labeled by Poly Pharmaceuticals, Inc., and CMS classifies it as a generic product.